Abstract:
The anti invasive and anti metastatic effects with new retinoid 4-acetamidophenyl retinoate(4-APR) were studied using
in vitro and
in vivo experiments. 4-APR, at the dose of 43.3 mg·kg
-1 ·day
-1 po, was shown to reduce the spontaneous lung metastatic foci of Lewis lung carcinoma. 4-APR was also found to inhibit the artificial lung metastasis of B16-F10 cells by 67.9% and 36.6% and suppress the reconstituted basement membrane invasion of B16-F10 cells by 54.2% and 41.9% at the concentrations of 10
-5 mol·L
-1 and 10
-6 mol·L
-1, respectively.